Biotech

All Articles

MBX aims for $136M IPO to take opponent to Ascendis into stage 3

.MBX has expanded programs to take in over $136 million coming from its own IPO as the biotech looks...

Relay breast cancer data tee up encounter AstraZeneca's Truqap

.Relay Rehabs has beaten its own survival objective in a first-in-human bust cancer research, positi...

AZ lays out AI-enabled TROP2 biomarker strategy for Daiichi ADC

.AstraZeneca has actually used expert system to formulate an unique biomarker for its Daiichi Sankyo...

AstraZeneca IL-33 medication neglects to boost COPD breathing in ph. 2

.AstraZeneca execs state they are actually "certainly not concerned" that the failure of tozorakimab...

BMS vet answers Foghorn's call for CBO-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of substantial management hirings, firings ...

Zenas, Bicara laid out to raise $180M-plus in separate IPOs

.After exposing plannings to reach the united state public markets less than a month back, Zenas Bio...

Psyence gets fellow psilocybin biotech Telepathic

.Psyence Biomedical is actually paying $500,000 in portions to acquire fellow psilocybin-based biote...

FDA concerned Iterum's urinary system infection medicine could lead to antimicrobial resistance

.5 months after approving Energy Therapies' Pivya as the very first brand new treatment for simple u...

Eli Lilly hops deeper right into AI with $409M Genetic Leap deal

.Eli Lilly has sprung in to an AI-enabled drug discovery package, partnering with RNA expert Genetic...

After FDA turndown and also layoffs, Lykos CEO is actually leaving behind

.Lykos chief executive officer and founder Amy Emerson is actually walking out, with principal opera...